The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

A new clinical trial suggests that semaglutide — the active ingredient in the widely used drugs Ozempic and Wegovy — may help ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

Ozempic is not an inherently bad drug — it has genuine medical uses and life-changing potential for those who need it. But ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

GLP-1 drugs have revolutionised the treatment of obesity, but the very reason they are effective is also why it's vital to ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

A new study has revealed that the ingredients of the popular weight loss drug Ozempic are linked to hair loss.According to ...

A new obesity 'wonder drug’ arrives on the Irish market today. The weight loss medication Wegovy, which is similar to Ozempic ...